|
ATE292622T1
(de)
*
|
1997-01-22 |
2005-04-15 |
Aventis Pharma Inc |
Substituierte beta-thiocarbonsäuren
|
|
US6696449B2
(en)
|
1997-03-04 |
2004-02-24 |
Pharmacia Corporation |
Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
|
|
NZ337326A
(en)
*
|
1997-03-04 |
2001-05-25 |
Monsanto Co |
Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds to inhibit the activity of matrix metalloproteinases
|
|
US6476027B1
(en)
|
1997-03-04 |
2002-11-05 |
Monsanto Company |
N-hydroxy 4-sulfonyl butanamide compounds
|
|
US6794511B2
(en)
*
|
1997-03-04 |
2004-09-21 |
G. D. Searle |
Sulfonyl aryl or heteroaryl hydroxamic acid compounds
|
|
US7115632B1
(en)
|
1999-05-12 |
2006-10-03 |
G. D. Searle & Co. |
Sulfonyl aryl or heteroaryl hydroxamic acid compounds
|
|
AUPO721997A0
(en)
*
|
1997-06-06 |
1997-07-03 |
Queensland Institute Of Medical Research, The |
Anticancer compounds
|
|
KR20010032319A
(ko)
|
1997-11-21 |
2001-04-16 |
로렌스 티. 마이젠헬더 |
매트릭스 메탈로프로테이나제 억제제로서 β-술포닐히드록스아민산의 α-히드록시, -아미노 및 -플루오로유도체
|
|
EP0965592A1
(en)
|
1998-06-18 |
1999-12-22 |
F. Hoffmann-La Roche Ag |
Process for preparing 3-arylsulfur hydroxamic acids
|
|
FR2780402B1
(fr)
*
|
1998-06-30 |
2001-04-27 |
Adir |
Nouveaux composes acides carboxyliques et hydroxamiques inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6479502B1
(en)
|
1998-08-29 |
2002-11-12 |
British Biotech Pharmaceuticals |
Hydroxamic acid derivatives as proteinase inhibitors
|
|
GB9919776D0
(en)
*
|
1998-08-31 |
1999-10-27 |
Zeneca Ltd |
Compoujnds
|
|
US6858598B1
(en)
|
1998-12-23 |
2005-02-22 |
G. D. Searle & Co. |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
GB9911075D0
(en)
|
1999-05-12 |
1999-07-14 |
Darwin Discovery Ltd |
HYdroxamic and carboxylic acid derivatives
|
|
GB9911073D0
(en)
*
|
1999-05-12 |
1999-07-14 |
Darwin Discovery Ltd |
Hydroxamic and carboxylic acid derivatives
|
|
GB9916562D0
(en)
*
|
1999-07-14 |
1999-09-15 |
Pharmacia & Upjohn Spa |
3-Arylsulfonyl-2-(substituted-methyl) propanoic acid derivatives as matrix metalloproteinase inhibitora
|
|
GB9922825D0
(en)
*
|
1999-09-25 |
1999-11-24 |
Smithkline Beecham Biolog |
Medical use
|
|
US6667316B1
(en)
*
|
1999-11-12 |
2003-12-23 |
Celgene Corporation |
Pharmaceutically active isoindoline derivatives
|
|
KR20020079882A
(ko)
*
|
2000-02-21 |
2002-10-19 |
아스트라제네카 아베 |
아릴피페라진 및 아릴피페리딘 및 금속단백질분해효소억제제로서의 그의 용도
|
|
GB0009760D0
(en)
|
2000-04-19 |
2000-06-07 |
Oxford Biomedica Ltd |
Method
|
|
EP1282614B1
(en)
|
2000-05-15 |
2003-11-12 |
Darwin Discovery Limited |
Hydroxamic acid derivatives
|
|
JP2003533513A
(ja)
|
2000-05-15 |
2003-11-11 |
ダーウィン・ディスカバリー・リミテッド |
Ｍｍｐおよびｔｎｆ阻害活性を有するヒドロキサム酸およびカルボン酸誘導体
|
|
EP1286994A1
(en)
*
|
2000-05-15 |
2003-03-05 |
Darwin Discovery Limited |
Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
|
|
GB0020498D0
(en)
|
2000-08-18 |
2000-10-11 |
Sterix Ltd |
Compound
|
|
US7842727B2
(en)
|
2001-03-27 |
2010-11-30 |
Errant Gene Therapeutics, Llc |
Histone deacetylase inhibitors
|
|
US7214831B2
(en)
*
|
2002-05-22 |
2007-05-08 |
Errant Gene Therapeutics, Llc |
Histone deacetylase inhibitors based on alpha-chalcogenmethylcarbonyl compounds
|
|
CA2344208A1
(en)
|
2001-04-30 |
2002-10-30 |
Oxford Biomedica (Uk) Limited |
Method
|
|
GB0119474D0
(en)
|
2001-08-09 |
2001-10-03 |
Astrazeneca Ab |
Compounds
|
|
EP1511477A4
(en)
|
2002-05-22 |
2008-04-09 |
Errant Gene Therapeutics Llc |
HISTONE DEACETYLASE INHIBITORS BASED ON ALPHA-KETO-EPOXYDE COMPOUNDS
|
|
DE10226370B4
(de)
|
2002-06-13 |
2008-12-11 |
Polyic Gmbh & Co. Kg |
Substrat für ein elektronisches Bauteil, Verwendung des Substrates, Verfahren zur Erhöhung der Ladungsträgermobilität und Organischer Feld-Effekt Transistor (OFET)
|
|
DE10233085B4
(de)
|
2002-07-19 |
2014-02-20 |
Dendron Gmbh |
Stent mit Führungsdraht
|
|
US8425549B2
(en)
|
2002-07-23 |
2013-04-23 |
Reverse Medical Corporation |
Systems and methods for removing obstructive matter from body lumens and treating vascular defects
|
|
US7102008B2
(en)
|
2002-08-01 |
2006-09-05 |
Bristol-Myers Squibb Company |
Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme
|
|
AU2003300076C1
(en)
|
2002-12-30 |
2010-03-04 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
|
GB0411562D0
(en)
|
2004-05-24 |
2004-06-23 |
Sterix Ltd |
Compound
|
|
GB0412492D0
(en)
|
2004-06-04 |
2004-07-07 |
Sterix Ltd |
Compound
|
|
US20050277897A1
(en)
*
|
2004-06-14 |
2005-12-15 |
Ghannoum Ziad R |
Handpiece tip
|
|
BRPI0610842A2
(pt)
*
|
2005-04-25 |
2010-07-27 |
Novartis Ag |
derivados de imidazo(1,2-a) piridina úteis como inibidores de peptìdeo desformilase (pdf)
|
|
DE102005019181A1
(de)
*
|
2005-04-25 |
2006-10-26 |
Novartis Ag |
Peptid-Deformylase (PDF) Inhibitoren 1
|
|
CA2609142C
(en)
|
2005-05-27 |
2016-02-09 |
Fondazione Centro San Raffaele Del Monte Tabor |
Therapeutic gene vectors comprising mirna target sequences
|
|
GB0513702D0
(en)
|
2005-07-04 |
2005-08-10 |
Sterix Ltd |
Compound
|
|
GB0526210D0
(en)
|
2005-12-22 |
2006-02-01 |
Oxford Biomedica Ltd |
Vectors
|
|
GB0604142D0
(en)
|
2006-03-01 |
2006-04-12 |
Sterix Ltd |
Compound
|
|
DK2041181T3
(da)
*
|
2006-06-08 |
2011-08-29 |
Helmholtz Zentrum Muenchen |
Specifikke proteaseinhibitorer og deres anvendelse i cancerterapi
|
|
ES2745411T3
(es)
*
|
2006-07-27 |
2020-03-02 |
Wang Nai Fang |
Compuestos y composiciones de arilsulfanilo para administración de agentes activos
|
|
GB0706072D0
(en)
|
2007-03-28 |
2007-05-09 |
Sterix Ltd |
Compound
|
|
US8088140B2
(en)
|
2008-05-19 |
2012-01-03 |
Mindframe, Inc. |
Blood flow restorative and embolus removal methods
|
|
US11337714B2
(en)
|
2007-10-17 |
2022-05-24 |
Covidien Lp |
Restoring blood flow and clot removal during acute ischemic stroke
|
|
GB0722779D0
(en)
|
2007-11-20 |
2008-01-02 |
Sterix Ltd |
Compound
|
|
EP2254485B1
(en)
|
2008-02-22 |
2017-08-30 |
Covidien LP |
Apparatus for flow restoration
|
|
DK2307551T3
(en)
|
2008-06-18 |
2017-03-20 |
Oxford Biomedica (Uk) Ltd |
CLEANING RETROVIRAL VECTORS
|
|
EP2364362B1
(en)
|
2008-11-12 |
2015-10-21 |
Ospedale San Raffaele S.r.l. |
Gene vector for inducing transgene-specific immune tolerance
|
|
PL2424571T3
(pl)
|
2009-04-30 |
2020-10-19 |
Ospedale San Raffaele S.R.L |
Wektor genowy
|
|
GB0914767D0
(en)
|
2009-08-24 |
2009-09-30 |
Sterix Ltd |
Compound
|
|
US9039749B2
(en)
|
2010-10-01 |
2015-05-26 |
Covidien Lp |
Methods and apparatuses for flow restoration and implanting members in the human body
|
|
WO2012156839A2
(en)
|
2011-05-19 |
2012-11-22 |
Ospedale San Raffaele S.R.L. |
New generation of splice-less lentiviral vectors for safer gene therapy applications
|
|
ES2627281T3
(es)
|
2013-02-06 |
2017-07-27 |
Merck Patent Gmbh |
Derivados del ácido carboxílico sustituidos como agregados agrecanasa para el tratamiento de la artrosis
|
|
AU2014229506B2
(en)
|
2013-03-11 |
2017-04-13 |
Nobesita As |
Natural lipids containing non-oxidizable fatty acids
|
|
US10076399B2
(en)
|
2013-09-13 |
2018-09-18 |
Covidien Lp |
Endovascular device engagement
|
|
EP3060670B1
(en)
|
2013-10-24 |
2019-07-10 |
Ospedale San Raffaele S.r.l. |
Method
|
|
GB201322798D0
(en)
|
2013-12-20 |
2014-02-05 |
Oxford Biomedica Ltd |
Production system
|
|
GB201407322D0
(en)
|
2014-04-25 |
2014-06-11 |
Ospedale San Raffaele |
Gene therapy
|
|
GB201412494D0
(en)
|
2014-07-14 |
2014-08-27 |
Ospedale San Raffaele And Fond Telethon |
Vector production
|
|
GB201418965D0
(https=)
|
2014-10-24 |
2014-12-10 |
Ospedale San Raffaele And Fond Telethon |
|
|
GB201608944D0
(en)
|
2016-05-20 |
2016-07-06 |
Ospedale San Raffaele And Fond Telethon |
Gene Tharapy
|
|
GB201706394D0
(en)
|
2017-04-21 |
2017-06-07 |
Ospedale San Raffaele Srl |
Gene Therapy
|
|
DE102017211110A1
(de)
*
|
2017-06-30 |
2019-01-03 |
Continental Reifen Deutschland Gmbh |
Verfahren zur Herstellung eines Silans, Verfahren zur Modifizierung einer Kieselsäure mit dem Silan und modifizierte Kieselsäure
|
|
GB201807945D0
(en)
|
2018-05-16 |
2018-06-27 |
Ospedale San Raffaele Srl |
Vector production
|
|
GB201807944D0
(en)
|
2018-05-16 |
2018-06-27 |
Ospedale San Raffaele Srl |
Compositions and methods for haematopoietic stem cell transplantation
|
|
AU2019294294A1
(en)
|
2018-06-25 |
2021-02-11 |
Fondazione Telethon Ets |
Gene therapy
|
|
WO2020074729A1
(en)
|
2018-10-11 |
2020-04-16 |
Ospedale San Raffaele S.R.L |
Selection by means of artificial transactivators
|
|
JP7677893B2
(ja)
|
2019-01-18 |
2025-05-15 |
ソシエテ・デ・プロデュイ・ネスレ・エス・アー |
幹細胞機能を向上させるための薬剤及び方法
|
|
WO2021094752A1
(en)
|
2019-11-12 |
2021-05-20 |
Oxford Biomedica (Uk) Limited |
Production system
|
|
EP4103723A1
(en)
|
2020-02-13 |
2022-12-21 |
Oxford BioMedica (UK) Limited |
Production of lentiviral vectors
|
|
WO2021181108A1
(en)
|
2020-03-13 |
2021-09-16 |
Oxford Biomedica (Uk) Limited |
Lentiviral vectors
|
|
GB202007106D0
(en)
|
2020-05-14 |
2020-07-01 |
Ucl Business Plc |
Cyclosporine analogues
|
|
GB202007199D0
(en)
|
2020-05-15 |
2020-07-01 |
Oxford Biomedica Ltd |
Viral vector production
|
|
CA3188667A1
(en)
|
2020-09-28 |
2022-03-31 |
Nicola Vannini |
Compositions and methods for increasing stem cell function
|
|
BR112023005370A2
(pt)
|
2020-09-28 |
2023-05-09 |
Nestle Sa |
Composições e métodos para aumentar função das células-tronco
|
|
GB202017725D0
(en)
|
2020-11-10 |
2020-12-23 |
Oxford Biomedica Ltd |
Method
|
|
CA3207166A1
(en)
|
2021-02-01 |
2022-08-04 |
Angelo Leone Lombardo |
Gene silencing
|
|
AU2021202658A1
(en)
|
2021-04-28 |
2022-11-17 |
Fondazione Telethon |
Gene therapy
|
|
AU2022270331A1
(en)
|
2021-05-05 |
2023-10-12 |
Ludwig Institute For Cancer Research |
Urolithin for increasing stem cell function
|
|
GB202114532D0
(en)
|
2021-10-12 |
2021-11-24 |
Oxford Biomedica Ltd |
Lentiviral Vectors
|
|
GB202114530D0
(en)
|
2021-10-12 |
2021-11-24 |
Oxford Biomedica Ltd |
Retroviral vectors
|
|
GB202114534D0
(en)
|
2021-10-12 |
2021-11-24 |
Oxford Biomedica Ltd |
Novel viral regulatory elements
|
|
GB202114529D0
(en)
|
2021-10-12 |
2021-11-24 |
Oxford Biomedica Ltd |
Lentiviral vectors
|
|
GB202114528D0
(en)
|
2021-10-12 |
2021-11-24 |
Oxford Biomedica Ltd |
Lentiviral vectors
|
|
GB202114972D0
(en)
|
2021-10-19 |
2021-12-01 |
Ospedale San Raffaele Srl |
Gene therapy
|
|
GB202117844D0
(en)
|
2021-12-09 |
2022-01-26 |
Oxford Biomedica Ltd |
Purification method
|
|
US20250281540A1
(en)
|
2022-04-28 |
2025-09-11 |
Ospedale San Raffaele S.R.L. |
Methods for Haematopoietic Stem Cell Transplantation
|
|
GB202206346D0
(en)
|
2022-04-29 |
2022-06-15 |
Ospedale San Raffaele Srl |
Gene therapy
|
|
GB202209098D0
(en)
|
2022-06-21 |
2022-08-10 |
Ucl Business Ltd |
Cyclosporine analogues
|
|
GB202211935D0
(en)
|
2022-08-16 |
2022-09-28 |
Oxford Biomedica Ltd |
envelope proteins
|
|
EP4602153A1
(en)
|
2022-10-11 |
2025-08-20 |
Fondazione Telethon ETS |
3d cell culture methods
|
|
IT202300011790A1
(it)
|
2023-06-08 |
2024-12-08 |
Fond Telethon Ets |
Protocolli di manipolazione genica in cellule immunitarie
|